[{"begin": 0, "end": 129, "text": "Roger, G., Lagnel, B., Besret, L., Bramoulle, Y., Coulon, C., Ottaviani, M., Kassiou, M., Bottlaender, M., Valette, H., Dolle, F.", "tokenized_text": "Roger , G . , Lagnel , B . , Besret , L . , Bramoulle , Y . , Coulon , C . , Ottaviani , M . , Kassiou , M . , Bottlaender , M . , Valette , H . , Dolle , F .", "type": "authors", "id": 0}, {"begin": 131, "end": 135, "text": "2003", "tokenized_text": "2003", "type": "year", "id": 1}, {"begin": 138, "end": 289, "text": "Synthesis, radiosynthesis and In Vivo evaluation of 5-[3-(4-Benzylpiperidin-1-yl) prop-1-ynyl]-1, 3-dihydrobenzoimidazol-2-[11C] one, as a potent NR 1A", "tokenized_text": "Synthesis , radiosynthesis and In Vivo evaluation of 5 - [ 3 - ( 4 - Benzylpiperidin - 1 - yl ) prop - 1 - ynyl ] - 1 , 3 - dihydrobenzoimidazol - 2 - [ 11C ] one , as a potent NR 1A", "type": "title", "id": 2}, {"begin": 289, "end": 331, "text": "/2B subtype selective NMDA PET radiotracer", "tokenized_text": "/ 2B subtype selective NMDA PET radiotracer", "type": "title", "id": 3}, {"begin": 333, "end": 367, "text": "Bioorganic and Medicinal Chemistry", "tokenized_text": "Bioorganic and Medicinal Chemistry", "type": "venue", "id": 4}]